Table of Contents
This BCC Research report looks at the current and future markets, and analyze technological, demographic and economic developments that may have a long-term impact on the size and structure of the market for minimally invasive devices and instruments.
Use this report to:
- Review the minimally invasive surgical devices industry and the U.S. market for these devices.
- Gain insight into major types and applications of minimally invasive surgical devices and instruments.
- Learn about the future of minimally invasive surgical devices and instruments.
- Receive information about profiles of key companies in the field.
- The global market for minimally invasive medical devices and equipment totaled $14.5 billion in 2013. The market reached roughly $15.4 billion in 2014 and is expected to reach $21.5 billion in 2019, registering a compound annual growth rate (CAGR) of 6.8% for the period 2014-2019.
- The U. S. as a segment will grow from about $10.2 billion in 2014 to about $ 14.0 billion by 2019 at a 6.4% CAGR for the period 2014-2019.
- Europe as a segment will grow from nearly $3.3 billion in 2014 to $4.8 billion in 2019, increasing at a CAGR of 7.9% from 2014-2019.
Introduction & Scope
MINIMALLY INVASIVE SURGERY
Minimally invasive surgery is performed without making a major incision or opening, resulting in fewer traumas for the patient and yielding significant cost savings. These
are results of shorter hospitalization times and reduced therapy requirements. Other benefits of minimally invasive surgery are less pain, less need for postsurgical pain
medication, less scarring and less likelihood of complications related to the incision. Thus, minimally invasive surgery is defined either as based on the operative procedure
(e.g., small incisions) or the outcome (reduced surgical complications or costs). However, minimally invasive is not the same as minor surgery. Some “minimally invasive” procedures (e.g., coronary artery bypass surgery) are still major operations requiring a hospital stay.
In minimally invasive surgery, a miniature camera is introduced into the body through a small incision. It transmits images to a video monitor, enabling the physician to
diagnose and, if necessary, treat a variety of conditions. To do this, the physician inserts surgical instruments and auxiliary devices, such as irrigation and drainage devices, through one or more small incisions. Minimally invasive procedures share some important characteristics with minimally invasive surgery but should not be confused with either ambulatory (“walk-in”) or noninvasive surgery.
This report details the actuals for 2009 and 2013, and compound annual growth rate (CAGR) projections for 2014 through 2019 for the North American, European, Far Eastern and Rest-of-World markets. Power source sales and values are provided under consensus, optimistic and pessimistic scenarios. A patent analysis and discussion for power sources and vehicle components describes where research is performed and emphasizes intellectual property issues.
As defined by BCC Research for this report, electric vehicles and fuel cell vehicles include the following:
- Hybrid electric vehicles (HEVs).
- Plug-in hybrid electric vehicles (PHEVs).
- Electric vehicles (pure EVs).
Specific types of vehicles using these batteries include:
- Passenger vehicles (sedans, microcars, SUVs, crossover SUVs, pickup trucks, sports cars).
- Low-velocity (golf carts, neighborhood electric vehicles, personal mobility devices).
- Scooters (two-wheelers, motorcycles, some three-wheelers).
- Commercial/industrial (material handling equipment, burden carriers, forklifts, trucks).
- Niche (military, locomotives).
These market sectors are defined, leading companies are identified and the markets analyzed (including a five-year market forecast). Finally, status and recent events for
power source maker companies are provided in the “Company Profiles” section.
Regions covered include:
- North America: Canada and the U.S.
- Far East: Japan, China, India, Indonesia, etc.
- Europe: Western Europe.
- Rest of World (ROW): South America, Mexico, Central America, Africa, Middle East, Australia, New Zealand, other Pacific nations, Russia, Eastern Europe and Turkey.
Get Industry Insights. Simply.
Talk to Veronica
+1 718 514 2762
Frontier Pharma: Head and Neck Cancer - Immunotherapies and Signal Transduction Inhibitors Dominate First-in-Class Innovation Summary Head and neck cancer (HNC) is the sixth most common malignancy worldwide, ...
Frontier Pharma: Versatile Innovation in Immunology - Large Therapy Area Pipeline with a High Degree of Repositioning Potential Summary Immunology is one of the largest therapy areas, with a total of 2,145 ...
“Medical Laboratory Testing Services reaches 12 billion tests per year. Genomic technology and China healthcare expansion driving global growth.....” Report Overview: A market that just keeps on growing. ...